台灣病理學會主辦分子能力測試 KRAS 2017

Request edit access

JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.

請填寫貴單位 ID: *

請參閱寄給貴單位的填表說明，裡面有附上貴單位之 ID

Institute: *

Testing personnel: *

Lab directors: *

E-mail: *

請填寫聯絡人的 E-mail 地址

Which method do you use for the detection of KRAS mutations? (可複選) *

A.PCR allele-specific (non-quantitative)

B.PCR, direct sequencing

C.Real-time PCR (home-brewed)

D. Commercial kit or other methods (請於下一題說明)

Required

使用 commercial kit or other methods 的種類 (若有使用請填寫)

Do you perform macrodissection or microdissection to enrich tumor cell populations before testing? *

A. Yes

B. No

Result

1.Please record the slide no. you received for this test:____________ *

KRAS01:

KARS02:

2.In the tumor that you received in this specimen, estimate the percentage of tumor cells present within the area you selected for DNA mutation analysis? *

KARS01: %

KRAS02: %

Results of KRAS mutation analysis (KRAS01) *

A. c.34G>A p.G12S

B. c.37G>C p.G13R

C. c.35G>C p.G12A

D. c.34G>T p.G12C

E. c.38G>A p.G13D

F. c.35G>T p.G12V

G.c.35G>A p.G12D

H. c.34G>C p.G12R

I. No variations detected

Other:

Results of KRAS mutation analysis (KRAS02) *

A. c.34G>A p.G12S

B. c.37G>C p.G13R

C. c.35G>C p.G12A

D. c.34G>T p.G12C

E. c.38G>A p.G13D

F. c.35G>T p.G12V

G.c.35G>A p.G12D

H. c.34G>C p.G12R

I. No variations detected

Other:

請問您對這次KRAS PT有無任何意見或建議? 歡迎您提供給學會參考，謝謝!

請注意：結果一旦送出即無法修改，請再次檢視您填寫的答案，確認無誤之後再按底下的「提交」按鈕。

Submit

Clear form

Never submit passwords through Google Forms.

This content is neither created nor endorsed by Google. - Terms of Service - Privacy Policy

Does this form look suspicious? Report

Forms